8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dioxaspiro(4.5)dec-7-ene → 4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-2-methyl-7-nitro-2,3-dihydro-1H-isoindol-1-one

참여 물질

역할	이름	HCID	투입량
반응물	8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dioxaspiro(4.5)dec-7-ene	HCID 3697076	—
반응물	4-Bromo-2-methyl-7-nitroisoindolin-1-one	HCID 53407894	—
반응물	1,4-dioxaspiro[4,5]dec-7-ene-8-yl-2-methyl-2,3-dihydro-1H-isoindol-1-one	HCID 86654039	—
생성물	4-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-2-methyl-7-nitro-2,3-dihydro-1H-isoindol-1-one	HCID 67255153	—

반응 단계

The title product was prepared according to the procedure for 7-amino-4-(1,4-dioxaspiro[4,5]dec-7-ene-8-yl-2-methyl-2,3-dihydro-1H-isoindol-1-one using 4-bromo-2-methyl-7-nitro-2,3-dihydro-1H-isoindol-1-one and 1,4-dioxaspiro[4,5]dec-7-ene-8-boronic acid pinacol ester.

출처 및 근거

DOI	10.6084/m9.figshare.5104873.v1
특허 번호	US09096624B2
출처 데이터셋	uspto-grants-2015_08
ORD ID	ord-72ed046144b6454f898c7e943b66f07e
출처 메모	uspto-grants-2015_08